Scopolamine-induced amnesia model: A possible anticholinergic mechanism with reversibility with statins and nootropic agents

Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2018, Vol 8, Issue 3

Abstract

Background: High cholesterol turnover is implicated in the pathogenesis of Alzheimer’s disease by causing β amyloid plaque deposition and selective degeneration of cholinergic neurons in brain whereas drugs currently used for the treatment of the same are based on mechanisms which are cholesterol independent. Aims and Objectives: The aim of the study is to find any cholesterol independent mechanisms such as antioxidant and cholinomimetic action of statins in a reversal of memory deficit in scopolamine-induced amnesia. Materials and Methods: Sixty young Swiss albino mice were divided equally into 10 groups, i.e., Group I to Group X. Group I–V and Group VI–X were subjected two exteroceptive behavioral models, i.e., passive avoidance paradigm and Morris water maze, (MWM) respectively. Group I and Group VI served as negative control. Carboxymethyl cellulose (CMC), atorvastatin, simvastatin (test drugs), and piracetam (standard drug), respectively, were given orally to Group II and VII, Group III and VIII, Group IV and IX, and Group V and X for 14 days before inducing amnesia using scopolamine (0.4 mg/kg body weight) injection i.p. Results: Step down latency of disease control group treated with CMC was significantly lower than that of the negative control group (42.5 ± 9.07 s vs. 147.5 ± 10.78 s) as well as that of statin and piracetam treated groups. Learning was good among all groups in MWM with a gradual decrease in escape latency from day 1 to day 4 but during memory retrieval test on day 5, CMC treated group performed poorly in comparison to others. There was no significant difference in plasma cholesterol levels among different groups whereas malondialdehyde was significantly lower among groups treated with statins or piracetam. Conclusion: Statins reversed the scopolamine-induced amnesia by some cholesterol independent mechanisms

Authors and Affiliations

Manas Ranjan Mishra, Niranjan Sahoo, Suresh Chandra Pradhan

Keywords

Related Articles

Investigation the barriers and factors influencing the scientific productions of graduate students in Hamadan University of Medical Sciences

Background: The current study was conducted to investigate the research barriers and challenges faced by graduate students in Hamadan University of Medical Sciences. Aims and Objectives: This study is among the applied s...

Arsenic trioxide-induced QT interval prolongation: A case report

QT prolongation refers to the prolonged QT interval in electrocardiography (ECG) which can even lead to life-threatening events such as ventricular arrhythmias, torsades de pointes, etc., several drugs can cause QT prolo...

 A rare cause of hypertension in a newborn: Adrenal hemorrhage

 Adrenal hemorrhage due to birth trauma is a complication that can be seen in neonates. The most common symptoms are anemia, prolonged jaundice, and a palpable mass in the abdomen. It can rarely lead to hypertensio...

 Effect of metformin on the spatial memory in aged rats

 Background: Aging process is often accompanied with some degree of decline in all the abilities, including learning and memory. One of the attracting research fields has been devoted to finding antiaging drugs. Me...

Sympathetic function tests during pre‑ and post‑menstrual phases in young women

Background: Women undergo many types of behavioral and hormonal changes, especially during reproductive life. Besides reproductive changes, there occur cyclical fluctuations in various functions of body systems. Autonomi...

Download PDF file
  • EP ID EP487173
  • DOI 10.5455/njppp.2018.8.1040114102017
  • Views 72
  • Downloads 0

How To Cite

Manas Ranjan Mishra, Niranjan Sahoo, Suresh Chandra Pradhan (2018). Scopolamine-induced amnesia model: A possible anticholinergic mechanism with reversibility with statins and nootropic agents. National Journal of Physiology, Pharmacy and Pharmacology, 8(3), 420-425. https://europub.co.uk/articles/-A-487173